Latest News & Updates

Breaking News

  • 3 hours ago

  • Vaibhavi M.

ANI Pharmaceuticals Launches Generic Isosorbide Mononitrate Tablets For Angina Treatment, Following FDA Approval
Breaking News
Plus Therapeutics Secures FDA Orphan Drug Designation For REYOBIQ In Pediatric Brain Tumours

Vaibhavi M.

Other trending news you may like to read

ANI Pharmaceuticals Launches Generic Isosorbide Mononitrate Tablets For Angina Treatment, Following FDA Approval

ANI Pharmaceuticals launches generic Isosorbide Mononitrate tablets for angina treatment following FDA approval, expanding access to affordable nitrate therapy options.

Vaibhavi M.

Pharma Now

Plus Therapeutics Secures FDA Orphan Drug Designation For REYOBIQ In Pediatric Brain Tumours

Plus Therapeutics gains FDA Orphan Drug Designation for REYOBIQ in pediatric malignant gliomas and ependymoma, advancing targeted radiotherapy for rare brain tumors.

Vaibhavi M.

Pharma Now

Cue Biopharma Secures $7.5M Milestone From Boehringer Ingelheim For Advancing Autoimmune Therapy Development

Cue Biopharma secures $7.5M milestone from Boehringer Ingelheim for advancing CUE-501 autoimmune therapy, supporting T cell-based approach targeting pathogenic B cells.

Vaibhavi M.

Pharma Now

Telix Expands Board With Appointments Of Maria Rivas And Bill Jellison To Strengthen Governance And Strategy

Telix Pharmaceuticals appoints Maria Rivas and Bill Jellison as Non-Executive Directors to strengthen governance, financial oversight, and strategic leadership for global growth.

Vaibhavi M.

Pharma Now